Mechanisms of late cardiovascular toxicity from cancer chemotherapy

Journal of Clinical Oncology

Volumn 23, Issue 36, 2005, Pages 9051-9052

  Steingart, Richard ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHOLESTEROL; CISPLATIN; ETOPOSIDE; VON WILLEBRAND FACTOR; ANTINEOPLASTIC AGENT;

ARTERY INTIMA PROLIFERATION; BLOOD PRESSURE MONITORING; BLOOD VESSEL REACTIVITY; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; EDITORIAL; GERM CELL TUMOR; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAYNAUD PHENOMENON; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HEART; MALE; NEOPLASM; NOTE; TESTIS TUMOR;

ANTINEOPLASTIC AGENTS; CARDIOVASCULAR DISEASES; HEART; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS;

EID: 33644821568     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.1731     Document Type: Editorial

References (13)

1. Nuver J, Smit AJ, van der Meer J, et al: Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol 23:9130-9137, 2005
2. Vogelzang NJ, Bosl GJ, Johnson K, et al: Raynaud's phenomenon: A common toxicity after combination chemotherapy for testicular cancer. Ann Intern Med 95:288-292, 1981
3. Meinardi MT, Gietema JA, van der Graaf WT, et al: Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 18:1725-1732, 2000
4. Huddart RA, Norman A, Shahidi M, et al: Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21:1513-1523, 2003
5. Sagstuen H, Aass N, Fossa SD, et al: Blood pressure and body mass index in long-term survivors of testicular cancer. J Clin Oncol 23:4980-4990, 2005
6. Strumberg D, Brugge S, Korn MW, et al: Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol 13:229-236, 2002
7. Bokemeyer C, Berger CC, Kuczyk MA: Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 14:2923-2932, 1996
8. Bissett D, Kunkeler L, Zwanenburg L, et al: Long-term sequelae of treatment for testicular germ cell tumours. Br J Cancer 62:655-659, 1990
9. Fossa SD, Aass N, Harvei S, et al: Increased mortality rates in young and middle-aged patients with malignant germ cell tumours. Br J Cancer 90:607-612, 2004
10. Bosl GJ, Leitner SP, Atlas SA, et al: Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors. J Clin Oncol 4:1684-1689, 1986
11. O'Leary DH, Polak JF, Kronmal RA, et al: Carotid-artery intima and medial thickness as a risk factor for myocardial infarction and stroke in older patients. N Engl J Med 340:14-22, 1999
12. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413-2446, 1997
13. National Institutes of Health: National Cholesterol Education Program, National Heart, Lung, and Blood Institute. Bethesda, MD, National Institutes of Health. NIH publication 01-3670, May 2001